Valuation: Laboratorio Reig Jofre, S.A.

Market Cap 213M 244M 197M 181M 342M 23.5B 350M 2.35B 925M 11.51B 917M 897M 39.63B P/E 2026 *
13.1x
P/E 2027 * 21.8x
Enterprise Value 298M 341M 275M 253M 478M 32.84B 488M 3.29B 1.29B 16.08B 1.28B 1.25B 55.37B EV / Sales 2026 *
0.82x
EV / Sales 2027 * 0.75x
Free-Float
20.57%
Yield 2026 *
-
Yield 2027 * -
Current month-2.60%
1 month-1.87%
3 months-3.32%
6 months-1.87%
Current year+1.95%
1 week 2.62
Extreme 2.62
2.67
1 month 2.62
Extreme 2.62
2.73
Current year 2.32
Extreme 2.32
2.94
1 year 2.32
Extreme 2.32
3.35
3 years 2.15
Extreme 2.15
3.4
5 years 2.02
Extreme 2.02
5.47
10 years 1.87
Extreme 1.87
6.4
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2006
Director of Finance/CFO - 20/12/2023
Chief Tech/Sci/R&D Officer - 01/01/2003
Director TitleAgeSince
Chairman - 31/12/2014
Director/Board Member 58 31/12/2014
Director/Board Member - 07/11/2017
Date Insider Type Main position Quantity % Market Cap.
5/11/26 A Buy 1,748 0.0021%
5/8/26 A Buy 1,748 0.0021%
5/4/26 A Buy 1,748 0.0021%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-12.08%+2.75% 244M
+0.85%-0.80%+54.84%+163.70% 1,051B
+1.23%-1.53%+55.26%+59.07% 609B
+0.04%+2.58%+32.96%+88.75% 450B
+0.78%-0.71%+30.04%+24.61% 330B
+1.41%+0.58%+33.92%+47.20% 284B
-0.27%-1.87%+22.13%+23.47% 263B
-1.76%+2.37%-22.19%-38.45% 223B
-1.42%+0.80%+22.81%+60.77% 198B
-1.48%+3.43%+23.42%+73.31% 167B
Average -0.11%+0.48%+24.11%+50.52% 357.53B
Weighted average by Cap. +0.22%+0.02%+37.75%+81.49%

Financials

2026 *2027 *
Net sales 365M 418M 337M 310M 585M 40.21B 598M 4.02B 1.58B 19.69B 1.57B 1.53B 67.8B 392M 448M 362M 333M 628M 43.19B 642M 4.32B 1.7B 21.15B 1.68B 1.65B 72.81B
Net income 16.7M 19.11M 15.41M 14.2M 26.77M 1.84B 27.37M 184M 72.45M 901M 71.77M 70.19M 3.1B 9.5M 10.87M 8.77M 8.08M 15.23M 1.05B 15.57M 105M 41.21M 513M 40.83M 39.93M 1.77B
Net Debt 84.7M 96.92M 78.16M 72.04M 136M 9.33B 139M 934M 367M 4.57B 364M 356M 15.74B 78.7M 90.06M 72.62M 66.94M 126M 8.67B 129M 868M 341M 4.25B 338M 331M 14.62B
Logo Laboratorio Reig Jofre, S.A.
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
Employees
1,400
Date Price Change Volume
17/07/26 €2.620 0.00% 1,784
16/07/26 €2.620 -1.13% 4,264
15/07/26 €2.650 0.00% 480
14/07/26 €2.650 -0.75% 2,481
13/07/26 €2.670 +1.91% 5,463
Trader
-
Investor
Global
-
Quality
ESG MSCI
-

Annual profits - Rate of surprise